Arena Pharmaceuticals, Inc. announces European Medicines Agency's acceptance of Lorcaserin marketing authorization application for weight control (BioSpace, 26 March 2012)

Growth in the womb and early infancy predicts bone size and strength in childhood (EurekAlert, 26 March 2012)

Amylin Pharmaceuticals, Inc., Eli Lilly and company receive EU OK for new Byetta use (BioSpace, 23 March 2012)

27 Mar 2012

The European Commission has accepted an extension to the marketing authorisation for type 2 diabetes treatment exenatide (Byetta) as an adjunctive therapy to basal insulin, with or without metformin and/or pioglitazone (Actos).

Share this story

Top stories

Call for nominations for Awards Committee Chair
30 Oct 2024

James M Tanner Award - 2025 nominations open
30 Oct 2024

Would you like to host the BSPED annual meeting?
21 Oct 2024

Most read